Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lisa Pietrogiovanna
Observed name:
L. Pietrogiovanna
Observed institutions:
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
Ospedale degli Infermi
ORCID:
0009-0007-2246-9124
Observed ORCID:
0009-0007-2246-9124
OpenAlex ID:
A5084581539
Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancer
2010
·
A. Sartore-Bianchi
, K. Bencardino
, et al.
·
Cancer Treatment Reviews
·
30
203P Treatment patterns and real-world outcomes of extensive-stage small cell lung cancer: A retrospective, multicenter study
2024
·
M. Cani
, L. Buffoni
, et al.
·
ESMO Open
·
2
Cavitation of lung metastases induced by regorafenib is associated with radiological response in metastatic colorectal cancer: data from the phase III correct study
2015
·
R. Ricotta
, S. Ghezzi
, et al.
·
Annals of Oncology
·
2
PDF
Is Codon 13 KRAS Mutation Biologically Different from Codon 12 Mutation?
2012
·
Alessio Amatu
, Andrea Sartore-Bianchi
, et al.
·
Current Colorectal Cancer Reports
·
2
Immune-related toxicities in non-small cell lung cancer: Real-life predictors of outcome to checkpoint inhibitors?
2019
·
Emanuela Romano
, Roberta Poli
, et al.
·
Journal of Clinical Oncology
·
1
The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy
2025
·
Salvatore Artale
, Francesca Filiali
, et al.
·
JMIR Research Protocols
Immune-related endocrine toxicities in non-small cell lung cancer: predictors of outcome to checkpoint inhibitors?
2019
·
Roberta Poli
, Clement Dumont
, et al.
·
Endocrine Abstracts
Pooled analysis of clinical outcome of patients with chemorefractory metastatic colorectal cancer treated within clinical studies based on individual molecular alterations at Niguarda Cancer Center
2015
·
A. Sartore-Bianchi
, A. Amatu
, et al.
·
Annals of Oncology
PDF
Phase II study of dacarbazine for metastatic colorectal cancer: Final results with MGMT analysis.
2013
·
Alessio Amatu
, Andrea Sartore Bianchi
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
37
H-index:
2
I10-index:
1
Year
Topic
Type